News
Zymeworks Snags
Zymeworks Snags $187M Deal With Merck to Discover Multi-Pronged Antibodies
Sanofi-Aventis to acquire TargeGen Inc.
Sanofi-Aventis to acquire TargeGen Inc., a US biopharmaceutical company
Somnus Therapeutics
Somnus Therapeutics Closes US$15M Series A Financing with CTI Life Sciences and Care Capital
Enobia Pharma Inc.
Enobia Pharma Inc. Raises US$50M from Current Investors in Series C Financing
ENOBIA PHARMA RECEIVES FDA ORPHAN DRUG DESIGNATION
Enobia Pharma Receives FDA Orphan Drug Designation
TARGEGEN ANNOUNCES INITIATION OF CLINICAL TRIAL
Targegen announces initiation of clinical trial